Should nonglucose containing peritoneal dialysis solutions be used in all patients to avoid long-term membrane injury? 2011

Peter G Blake
Division of Nephrology, University of Western Ontario, London, Ontario, Canada. peter.blake@lhsc.on.ca

UI MeSH Term Description Entries
D010530 Peritoneal Dialysis Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure. Dialyses, Peritoneal,Dialysis, Peritoneal,Peritoneal Dialyses
D010532 Peritoneal Diseases Pathological processes involving the PERITONEUM. Peritoneal Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015314 Dialysis Solutions Solutions prepared for exchange across a semipermeable membrane of solutes below a molecular size determined by the cutoff threshold of the membrane material. Dialysate,Dialysis Solution,Dialyzate,Dialysates,Dialyzates,Solution, Dialysis,Solutions, Dialysis

Related Publications

Peter G Blake
August 1998, The International journal of artificial organs,
Peter G Blake
October 2015, Journal of clinical pharmacy and therapeutics,
Peter G Blake
July 1998, Advances in renal replacement therapy,
Peter G Blake
November 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Peter G Blake
January 2001, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
Peter G Blake
January 2015, Blood purification,
Peter G Blake
March 1979, Polskie Archiwum Medycyny Wewnetrznej,
Peter G Blake
January 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
Copied contents to your clipboard!